MLR-1023: Phase IIa data

A double-blind, U.S. and South Korean Phase IIa trial in 130 Type II diabetics showed that oral MLR-1023 for 4

Read the full 201 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE